Sanesco™ announced a strategic alliance with LDN, Germany, a world-class reference and research laboratory, at the ACAM conference. The alliance provides Sanesco™ with LDN's proven processes and assures total accuracy in Sanesco™'s tests. In addition, both companies committed to undertake joint R&D efforts designed to expand the knowledge base and broaden the clinical application of neurotransmitter and hormone markers. Pictured are Hector Romero, CEO & President of Sanesco™ International (left) and Dr. Bernhard Manz, President and Laboratory Director of LDN Germany (right).